Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally.. It offers API's for oncology and other therapeutic areas; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the generation and sale of wind power. Shilpa Medicare Limited was founded in 1987 and is headquartered in Raichur, India. The ISIN of this stock is INE790G01031.